4//SEC Filing
Shenouda Maged 4
Accession 0001213900-25-121973
CIK 0001553643other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:30 AM ET
Size
7.0 KB
Accession
0001213900-25-121973
Insider Transaction Report
Form 4
Shenouda Maged
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-12-15$4.12/sh+11,665$48,060→ 800,000 total - Award
Stock Appreciation Rights
2025-12-12+828,000→ 828,000 totalExercise: $4.06From: 2026-03-12Exp: 2035-12-12→ Common Stock (828,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658369
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:30 AM ET
- Size
- 7.0 KB